The Claim
Zinc lozenges containing zinc compounds with a first stability constant ≤1.7 demonstrated clinical efficacy in 5 out of 6 trials, whereas those with higher stability constants showed efficacy in only 2 out of 9 trials (p<0.02), suggesting that chemical stability predicts clinical efficacy.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Zinc lozenges with certain chemical properties worked well in most tests, while others didn't work as often. This shows that how stable the zinc is might predict if it will work for you.
See the scientific wording
Zinc lozenges with zinc compounds having a first stability constant of 1.7 or less succeeded in 5 of 6 trials, while those with higher stability constants succeeded in only 2 of 9 trials (p<0.02), indicating that chemical stability predicts clinical efficacy.
What the research says
1 studyStudy: Zinc lozenges as cure for the common cold – A review and hypothesis
The study looked at zinc lozenges and found that ones with certain chemical properties worked better, exactly matching the claim about why some zinc lozenges help with colds and others don't.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.